Coverage
-
July 30, 2026
A Delaware bankruptcy judge on Thursday approved biotechnology investor Apple Tree Life Sciences Inc.'s bid to deploy another $4 million in Chapter 11 to support its portfolio companies, after the debtor and its new independent directors reached a deal on the interim funding.
10 other articles on this case.
View all »